Evidence map›Paper›PMID 39283755›Full record

ArticleThe journal of pathology. Clinical research2024

The expression of YAP1 and other transcription factors contributes to lineage plasticity in combined small cell lung carcinoma.

Naoe Jimbo, Chiho Ohbayashi, Tomomi Fujii, Maiko Takeda, Suguru Mitsui, Yugo Tanaka, Tomoo Itoh, Yoshimasa Maniwa

Abstract read
In one paragraph

Article in The journal of pathology. Clinical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Naoe JimboDepartment of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.ORCID 0000-0003-0423-3568
Chiho OhbayashiDepartment of Diagnostic Pathology, Shinko Hospital, Kobe, Japan.
Tomomi FujiiDepartment of Diagnostic Pathology, Nara Medical University, Kashihara, Japan.
Maiko TakedaDepartment of Diagnostic Pathology, Nara Medical University, Kashihara, Japan.
Suguru MitsuiDivision of Thoracic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Yugo TanakaDivision of Thoracic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Tomoo ItohDepartment of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
Yoshimasa ManiwaDivision of Thoracic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Funding

JSPS (Japan Society for the Promotion of Science) KAKENHI JP19K18213JSPS (Japan Society for the Promotion of Science) KAKENHI JP 22K16172
6 · The paper itself

Abstract

Lineage plasticity in small cell lung carcinoma (SCLC) causes therapeutic difficulties. This study aimed to investigate the pathological findings of plasticity in SCLC, focusing on combined SCLC, and elucidate the involvement of YAP1 and other transcription factors. We analysed 100 surgically resected SCLCs through detailed morphological observations and immunohistochemistry for YAP1 and other transcription factors. Component-by-component next-generation sequencing (n = 15 pairs) and immunohistochemistry (n = 35 pairs) were performed on the combined SCLCs. Compared with pure SCLCs (n = 65), combined SCLCs (n = 35) showed a significantly larger size, higher expression of NEUROD1, and higher frequency of double-positive transcription factors (p = 0.0009, 0.04, and 0.019, respectively). Notably, 34% of the combined SCLCs showed morphological mosaic patterns with unclear boundaries between the SCLC and its partner. Combined SCLCs not only had unique histotypes as partners but also represented different lineage plasticity within the partner. NEUROD1-dominant combined SCLCs had a significantly higher proportion of adenocarcinomas as partners, whereas POU2F3-dominant combined SCLCs had a significantly higher proportion of squamous cell carcinomas as partners (p = 0.006 and p = 0.0006, respectively). YAP1 expression in SCLC components was found in 80% of combined SCLCs and 62% of pure SCLCs, often showing mosaic-like expression. Among the combined SCLCs with component-specific analysis, the identical TP53 mutation was found in 10 pairs, and the identical Rb1 abnormality was found in 2 pairs. On immunohistochemistry, the same abnormal p53 pattern was found in 34 pairs, and Rb1 loss was found in 24 pairs. In conclusion, combined SCLC shows a variety of pathological plasticity. Although combined SCLC is more plastic than pure SCLC, pure SCLC is also a phenotypically plastic tumour. The morphological mosaic pattern and YAP1 mosaic-like expression may represent ongoing lineage plasticity. This study also identified the relationship between transcription factors and partners in combined SCLC. Transcription factors may be involved in differentiating specific cell lineages beyond just 'neuroendocrine'.

Indexed as

Adaptor Proteins, Signal TransducingLung NeoplasmsSmall Cell Lung CarcinomaTranscription FactorsYAP-Signaling ProteinsAgedBasic Helix-Loop-Helix ProteinsBiomarkers, TumorCell LineageCell PlasticityFemaleHumansImmunohistochemistryMaleMiddle AgedMutationAdaptor Proteins, Signal TransducingBasic Helix-Loop-Helix ProteinsBiomarkers, TumorTranscription FactorsTumor Suppressor Protein p53YAP1 protein, humanYAP-Signaling Proteinscombined small cell lung carcinomamolecular markermosaicplasticitysmall cell carcinomasmall cell lung carcinomatranscription factorsYAP1

Identifiers

PMID39283755
PMCPMC11404481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.